PEAK6 Investments’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$497K Buy
74,267
+17,126
+30% +$176K ﹤0.01% 2313
2024
Q2
$666K Buy
57,141
+27,037
+90% +$325K ﹤0.01% 2085
2024
Q1
$321K Sell
30,104
-15,774
-34% -$125K ﹤0.01% 2750
2023
Q4
$266K Buy
45,878
+5,570
+14% +$39.3K ﹤0.01% 3052
2023
Q3
$405K Buy
40,308
+16,991
+73% +$196K ﹤0.01% 2541
2023
Q2
$277K Buy
23,317
+2,357
+11% +$24.2K ﹤0.01% 2662
2023
Q1
$167K Buy
20,960
+4,272
+26% +$39.3K ﹤0.01% 3223
2022
Q4
$162K Buy
16,688
+5,629
+51% +$60.9K ﹤0.01% 3403
2022
Q3
$129K Sell
11,059
-12,258
-53% -$155K ﹤0.01% 3942
2022
Q2
$277K Buy
+23,317
New +$303K ﹤0.01% 4456

Other funds holding GHRS

PEAK6 Investments's GHRS Position: Q3 2024 in Review

PEAK6 Investments increased its GH Research (GHRS) stake by 30% in Q3 2024, buying an estimated $176K and bringing the position to 74,267 shares worth $497K. The position accounts for ﹤0.01% of the portfolio, ranked #2313.

PEAK6 Investments first reported a position in GHRS in Q2 2022 and has held it in 10 quarters since. The position peaked at $666K in Q2 2024. 28 funds tracked by Wall St. Rank hold GHRS as of Q3 2024.

  • PEAK6 Investments held 74,267 shares of GH Research worth $497K as of Q3 2024.
  • PEAK6 Investments bought 17,126 GH Research shares in Q3 2024, an estimated $176K.
  • GH Research made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2313 holding.
  • PEAK6 Investments first reported a position in GH Research in Q2 2022 and has held it in 10 quarters since.
  • PEAK6 Investments's GH Research position peaked at $666K in Q2 2024.
  • 28 funds tracked by Wall St. Rank held GH Research as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.